Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Pituitary Neoplasms 1

Interventions

pasireotide 4Temozolomide 2lutetium Lu 177 dotatate 1farletuzumab 1antineoplaston AS 2-1 1antineoplaston A10 1Tranexamic Acid 1Thyrotropin-Releasing Hormone 1TBR-760 1Rosiglitazone 1Nivolumab 1Microarray Analysis 1Lapatinib 1Ipilimumab 1DNA Methylation 1Complementary Therapies 1Capecitabine 1Cabergoline 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Pituitary Neoplasms × TBR-760 × Clear all
NCT04335357 2020-04-06

TBR-760 in Adult Patients With Non-Functioning Pituitary Adenomas

Tiburio Therapeutics

Phase 2 Unknown
150 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡